Editorial: Tumor microenvironment immunophenotypes and disease progression

Ana Carolina Monteiro; Ana Paula Lepique; Martin Bonamino; Mercedes Beatriz Fuertes

doi:10.3389/fimmu.2023.1141084

Editorial: Tumor microenvironment immunophenotypes and disease progression

Front Immunol. 2023 Jan 24:14:1141084. doi: 10.3389/fimmu.2023.1141084. eCollection 2023.

Authors

Ana Carolina Monteiro^{1

2}, Ana Paula Lepique³, Martin Bonamino^{4

5}, Mercedes Beatriz Fuertes⁶

Affiliations

¹ Osteo and tumor immunology laboratory (LOIT), Biology Institute (EGB), Fluminense Federal University (UFF), Rio de Janeiro, Brazil.
² Laboratory on Thymus Research, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
³ Instituto de Ciências Biomédicas, Universidade de São Paulo, Department of Immunology, São Paulo, Brazil.
⁴ Programa de Carcinogeênese Molecular, National Cancer Institute (INCa), Rio de Janeiro, Brazil.
⁵ Vice-presidência de pesquisa e coleções biológicas, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
⁶ Laboratorio de Fisiopatología de la Inmunidad Innata, Instituto de Biología y Medicina Experimental (IBYME), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina.

No abstract available

Keywords: biomarker; disease progression; immunophenotypes; tumor immunity; tumor microenvironment (TME); tumor-infiltrating immune cells.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Disease Progression
Humans
Tumor Microenvironment*

Grants and funding

This work was supported by funds from Faperj (Foundation for Research Support of the State of Rio de Janeiro, ACM and MB); FOPESQ UFF (Programa de Fomento a Pesquisa da Universidade Federal Fluminense, ACM); CNPq (National Research Council, APL and MB); FAPESP (São Paulo Estate Research Foundation, APL); CONICET (National Research Council of Argentina, MF) and ANPCYT (National Agency for Promotion of Science and Technology from Argentina, MF).